Hypopituitarism can be described as a "malfunction of the endocrine command center", with an annual incidence of 4.2 per 100,000 population. Seventy-five percent of patients present with the initial tetrad of "three lows and one high": hypothermia (core temperature < 35.5°C), hypotension (systolic blood pressure < 90 mmHg), hypoglycemia (fasting blood glucose < 3.0 mmol/L), and severe fatigue (Epworth Sleepiness Scale score > 12). The average interval from symptom onset to definitive diagnosis is 14.3 months, which raises the risk of adrenal crisis by 6.8 times.

I. Target Organ Effects Caused by Hormone Deficiencies in Hypopituitarism

Thyroid Axis Dysfunction

• Suppressed metabolism: Basal metabolic rate reduced by over 35% (normal range: −10% to +15%)

• Thermoregulatory disturbance: Persistent cold intolerance even at ambient temperatures above 30°C, requiring thick outerwear in summer

• Cutaneous lesions: Dry, scaling skin with stratum corneum moisture content < 10% (normal > 20%). Skin biopsies of TSH-deficient patients reveal sebaceous gland atrophy in 89.3% of cases.

Collapsed Gonadal Axis

• Excessive hair loss: Monthly loss of more than 150 axillary and pubic hairs (normal < 50 hairs)

• Regression of secondary sexual characteristics: Male beard growth slowed by over 80% (less than 0.2 mm weekly)

• Reproductive impairment: Amenorrhea lasting over six months occurs in 92.7% of female patients.

II. Adrenocortical Insufficiency Secondary to Hypopituitarism

Impaired Stress Response

• Hypoglycemic coma: Blood glucose drops below 2.8 mmol/L after 4 hours of fasting (normal baseline > 3.9 mmol/L)

• Orthostatic circulatory collapse: Systolic blood pressure decreases by more than 30 mmHg after 3 minutes of standing

• Laboratory marker: 8 a.m. serum cortisol < 3 μg/dL (normal reference range: 5–25 μg/dL)

Disturbed Pigment Metabolism

• General pallor: Melanocyte activity in facial skin reduced by over 60%

• Hypopigmented scars: Faded old scars with a ΔL value > 15 compared with surrounding intact skin

• Underlying mechanism: Disrupted ACTH–MSH signaling pathway.

III. Impaired Growth and Metabolic Regulation

Manifestations of Growth Hormone Deficiency

• Abnormal fat distribution: Waist-to-hip ratio > 0.9 with excess visceral fat accumulation

• Sarcopenia: Limb muscle mass declines by over 5% annually (normal loss < 1%)

• Delayed wound healing: Skin lesions take 2.3 times longer to repair than healthy individuals.

Altered Prolactin Secretion

• Postpartum agalactorrhea: Daily milk output < 50 mL (normal lactation output > 500 mL)

• Suppressed sexual function: Erectile dysfunction in males (IIEF-5 score < 10)

• Deteriorated bone metabolism: Annual bone mineral density loss > 3% (normal < 0.5%).

IV. Etiological Classification of Hypopituitarism

Pituitary Neoplasm-Related Damage

• Postoperative hypopituitarism: Occurs in 38.7% of patients after pituitary adenoma resection

• Mass compression mechanism: Pituitary stalk compression rate reaches 91.4% for tumors > 2 cm in diameter

• Typical presentation: Combined deficiency of ≥3 pituitary hormones accounts for 68.3% of cases.

Postpartum Pituitary Necrosis (Sheehan’s Syndrome)

• Primary trigger: Peripartum hemorrhage exceeding 1,500 mL (21.4% incidence among severe bleeding cases)

• Symptom window: 87.6% of patients develop clinical manifestations within 6 weeks after delivery

• Classic triad: Agalactorrhea + persistent amenorrhea + extreme fatigue.

Inflammatory and Vascular Pituitary Lesions

• Lymphocytic hypophysitis: Anti-pituitary antibody positivity rate 76.5%

• Pituitary apoplexy: Sudden severe headache accompanied by acute vision loss and rapid hormonal collapse within 24 hours

• Imaging hallmark: Loss of the bright posterior pituitary signal on MRI (98.2% diagnostic specificity).

V. Atypical Symptoms in Special Populations

Children and Adolescents

• Growth arrest: Annual height gain < 4 cm with bone age delayed by more than 2 years

• Delayed puberty: Absence of secondary sexual characteristics by age 14 (testicular volume < 4 mL in boys)

• Cognitive impairment: Working memory scores fall 2 standard deviations below age-matched peers.

Elderly Patients

• Isolated hormonal deficiency: Isolated ACTH insufficiency accounts for 63.4% of elderly cases (young patients usually suffer multi-axis involvement)

• Insidious progression: Fatigue persists for over 3 years before diagnosis, with an average diagnostic delay of 26.8 months

• High misdiagnosis risk: 58.9% of elderly patients are initially misdiagnosed with depression.

Frequently Asked Questions on Hypopituitarism

Q1: What are the major life-threatening hazards of hypopituitarism?

Four tiers of severe clinical risks:

1. Metabolic crisis: Spontaneous hypoglycemic coma (12.3% mortality rate)

2. Circulatory failure: Shock triggered by infectious stress requiring emergent hydrocortisone therapy

3. Permanent infertility: Over 90% of untreated patients develop irreversible amenorrhea or azoospermia

4. Accelerated senescence syndrome: Bone age advances more than 10 years beyond chronological age.

Q2: How are the etiologies of hypopituitarism categorized?

Five major pathogenic categories:

1. Neoplastic (41.7%): Pituitary adenoma, craniopharyngioma

2. Iatrogenic (28.3%): Post-surgical or post-radiation pituitary injury

3. Vascular (15.6%): Severe postpartum hemorrhage, pituitary apoplexy

4. Inflammatory (9.8%): Autoimmune lymphocytic hypophysitis

5. Idiopathic (4.6%): Primary hypothalamic regulatory dysfunct

Note: Diagnosis requires thin-slice pituitary MRI plus a full panel of pituitary hormone testing.